These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35980858)

  • 1. Defining ambulation status in patients with Duchenne muscular dystrophy using the 10-metre walk test and the motor function measure scale.
    Petian-Alonso DC; de Castro AC; Barroso de Queiroz Davoli G; Martinez EZ; Mattiello-Sverzut AC
    Disabil Rehabil; 2023 Sep; 45(18):2984-2988. PubMed ID: 35980858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knee Strength and Ankle Range of Motion Impacts on Timed Function Tests in Duchenne Muscular Dystrophy: In the Era of Glucocorticoids.
    Duong T; Canbek J; Fernandez-Fernandez A; Henricson E; Birkmeier M; Siener C; Tesi Rocha C; McDonald C; Gordish-Dressman H;
    J Neuromuscul Dis; 2022; 9(1):147-159. PubMed ID: 34719507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial.
    Hafner P; Bonati U; Rubino D; Gocheva V; Zumbrunn T; Gueven N; Fischer D
    Trials; 2016 Aug; 17(1):389. PubMed ID: 27488051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Reliability of the Functional Evaluation Scale for Duchenne Muscular Dystrophy, Gait Domain: A Pilot Study.
    de Carvalho EV; Hukuda ME; Escorcio R; Voos MC; Caromano FA
    Physiother Res Int; 2015 Sep; 20(3):135-46. PubMed ID: 25521365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI Assessment of Motor Capabilities in Patients with Duchenne Muscular Dystrophy According to the Motor Function Measure Scale.
    Suslov V; Suslova G; Lytaev S
    Tomography; 2022 Apr; 8(2):948-960. PubMed ID: 35448710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Energy expenditure, body composition, and prevalence of metabolic disorders in patients with Duchenne muscular dystrophy.
    Saure C; Caminiti C; Weglinski J; de Castro Perez F; Monges S
    Diabetes Metab Syndr; 2018; 12(2):81-85. PubMed ID: 28869151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy.
    Fischmann A; Hafner P; Gloor M; Schmid M; Klein A; Pohlman U; Waltz T; Gonzalez R; Haas T; Bieri O; Fischer D
    J Neurol; 2013 Apr; 260(4):969-74. PubMed ID: 23138982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring changes and predicting loss of ambulation in Duchenne muscular dystrophy with the Motor Function Measure.
    Vuillerot C; Girardot F; Payan C; Fermanian J; Iwaz J; De Lattre C; Berard C
    Dev Med Child Neurol; 2010 Jan; 52(1):60-5. PubMed ID: 19453691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor function measure scale, steroid therapy and patients with Duchenne muscular dystrophy.
    Silva EC; Machado DL; Resende MB; Silva RF; Zanoteli E; Reed UC
    Arq Neuropsiquiatr; 2012 Mar; 70(3):191-5. PubMed ID: 22392111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responsiveness and Minimal Clinically Important Difference of the Chinese Version of the Motor Function Measure-32 in Children and Adolescents with Duchenne Muscular Dystrophy.
    Huang M; Chen T; Wang Y; Zhou C; Cao J; Lu X
    Dev Neurorehabil; 2022 Aug; 25(6):370-377. PubMed ID: 34964685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroids in Duchenne muscular dystrophy: impact on the motor function measure sensitivity to change and implications for clinical trials.
    Schreiber A; Brochard S; Rippert P; Fontaine-Carbonnel S; Payan C; Poirot I; Hamroun D; Vuillerot C;
    Dev Med Child Neurol; 2018 Feb; 60(2):185-191. PubMed ID: 28990163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative muscle MRI: A powerful surrogate outcome measure in Duchenne muscular dystrophy.
    Bonati U; Hafner P; Schädelin S; Schmid M; Naduvilekoot Devasia A; Schroeder J; Zuesli S; Pohlman U; Neuhaus C; Klein A; Sinnreich M; Haas T; Gloor M; Bieri O; Fischmann A; Fischer D
    Neuromuscul Disord; 2015 Sep; 25(9):679-85. PubMed ID: 26096788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor assessment in patients with Duchenne muscular dystrophy.
    Diniz GP; Lasmar LM; Giannetti JG
    Arq Neuropsiquiatr; 2012 Jun; 70(6):416-21. PubMed ID: 22699538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gait deviations in Duchenne muscular dystrophy-Part 2. Statistical non-parametric mapping to analyze gait deviations in children with Duchenne muscular dystrophy.
    Goudriaan M; Van den Hauwe M; Simon-Martinez C; Huenaerts C; Molenaers G; Goemans N; Desloovere K
    Gait Posture; 2018 Jun; 63():159-164. PubMed ID: 29751322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal timed function tests in Duchenne muscular dystrophy: ImagingDMD cohort natural history.
    Arora H; Willcocks RJ; Lott DJ; Harrington AT; Senesac CR; Zilke KL; Daniels MJ; Xu D; Tennekoon GI; Finanger EL; Russman BS; Finkel RS; Triplett WT; Byrne BJ; Walter GA; Sweeney HL; Vandenborne K
    Muscle Nerve; 2018 Nov; 58(5):631-638. PubMed ID: 29742798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambulatory Duchenne muscular dystrophy children: cross-sectional correlation between function, quantitative muscle ultrasound and MRI.
    Abdulhady H; Sakr HM; Elsayed NS; El-Sobky TA; Fahmy N; Saadawy AM; Elsedfy H
    Acta Myol; 2022 Mar; 41(1):1-14. PubMed ID: 35465338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gait and Sit-To-Stand Motor Compensation Strategies in Children and Adolescents With Duchenne Muscular Dystrophy.
    Dazzi MAR; Sá CDSC
    Percept Mot Skills; 2023 Feb; 130(1):221-238. PubMed ID: 36121164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of gait in Duchenne Muscular Dystrophy: Relation of 3D gait analysis to clinical assessment.
    Romano A; Favetta M; Schirinzi T; Summa S; Minosse S; D'Amico A; Catteruccia M; Petrarca M; Castelli E; Bertini E; Vasco G
    Neuromuscul Disord; 2019 Dec; 29(12):920-929. PubMed ID: 31791868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinesiology Taping in Duchenne Muscular Dystrophy: Acute Effects on Performance, Gait Characteristics, and Balance.
    Aydin Yağcioğlu G; Alemdaroğlu Gürbüz İ; Karaduman A; Bulut N; Yilmaz Ö
    Dev Neurorehabil; 2021 Apr; 24(3):199-204. PubMed ID: 33143504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of the gait profile score and gait variable score in individuals with Duchenne Muscular Dystrophy.
    Souza MA; Cezarani A; Lizzi EADS; Davoli GBQ; Mattiello SM; Jones R; Mattiello-Sverzut AC
    J Biomech; 2020 Jan; 98():109485. PubMed ID: 31771784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.